SUMMARY: A consortium led by U.S. investment firm RedBird Capital Partners has agreed to buy the Telegraph Media Group, publisher of the 170-year-old Daily Telegraph, for about £500 million ($674 million). This ends a lengthy takeover saga for the conservative-leaning newspaper, formerly owned by Britain’s Barclay family. RedBird plans to grow the brand domestically and internationally, invest in technology, and expand subscribers. The group, also publishing The Spectator (sold separately in September), was put up for sale two years ago to settle family debts. Previous consortium attempts involving foreign state interests were blocked by the UK government.

Read the full article

The post US investment firm Redbird agrees to buy Britain’s venerable Telegraph newspaper appeared first on www.clickorlando.com

SUMMARY: The grand opening of Universal’s Epic Universe in Orlando sparks a renewed theme park rivalry, energizing local tourism and economic leaders. Visitors praise the park’s modern design and immersive experiences, contrasting it with older parks’ limitations. This new addition intensifies competition with Disney, which plans expansions at Magic Kingdom to maintain its nostalgic appeal while embracing innovation. Orlando tourism experts see the rivalry as a global spotlight on the region, boosting its allure as a top vacation destination. The parks’ ongoing growth, dating back to Universal Studios’ 1990 debut, suggests Orlando’s theme park industry is far from reaching its peak.

Economic leaders say Orlando has become an unrivaled destination in the global theme park industry, and the debut of Universal’s Epic Universe is adding new momentum — and new pressure — to an already competitive market.

Subscribe to FOX 35 Orlando: https://bit.ly/3ACagaO
Watch FOX 35 Orlando LIVE newscasts: https://www.FOX35Orlando.com/live
Download FOX 35 news & weather apps: https://www.fox35orlando.com/apps

FOX 35 Orlando delivers breaking news, live events and press conferences, investigations, politics, entertainment, business news and local news stories and updates from Orlando, Orlando metro, and across Florida.

Watch more from FOX 35 on YouTube
Newest videos: https://www.youtube.com/myfoxorlando/videos
Most viewed/viral videos: https://www.youtube.com/watch?v=jgNn6rfByAM&list=PLzmRitN2dDZvlKw0C1IH3nLFGlbqgvp5C
We Love Florida: https://www.youtube.com/playlist?list=PLzmRitN2dDZuWecugac4QebPGp5-HZ5XP
Central Florida’s True Crime Files: https://www.youtube.com/watch?v=QAxwHLIeahA&list=PLzmRitN2dDZvk9zWypuHs9n38zuwnUSpx

More news stories: http://www.FOX35Orlando.com
Watch FOX 35 News live: https://fox35orlando.com/live
FOX 35 News newsletter: https://www.fox35orlando.com/email

Follow FOX 35 Orlando on Facebook: https://www.facebook.com/FOX35Orlando
Follow FOX 35 Orlando on Twitter: https://twitter.com/fox35orlando
Follow FOX 35 Orlando on Instagram: https://www.instagram.com/fox35orlando

Source

SUMMARY: The FDA has approved the weight loss drug Tzepatide (Mounjaro/Zepbound), a GLP-1 originally for diabetes and weight management, for treating obstructive sleep apnea. Sleep apnea causes breathing interruptions during sleep due to throat muscle relaxation, often linked to excess weight. Pulmonologist Dr. Samuel Gerovich explains that weight loss reduces apnea severity. Patients like Owen Wild report improved sleep and quality of life without significant side effects, though lifestyle habits remain essential. This approval may enhance access and affordability amid previous GLP-1 shortages. The drug’s impact on sleep apnea is largely through its weight loss benefits, not a direct sleep mechanism.

Weight loss drugs known as GLP1s are all the rage right now. They were originally developed for diabetes and weight management, but other “off label” uses are becoming more mainstream.

Source